{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T16:46:58Z","timestamp":1648658818681},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1093\/labmed\/lmx048","type":"journal-article","created":{"date-parts":[[2017,7,16]],"date-time":"2017-07-16T07:06:25Z","timestamp":1500188785000},"page":"262-265","source":"Crossref","is-referenced-by-count":1,"title":["Intra-Pericardial Use of Recombinant Factor VIIa in a Patient With Acute Hemorrhagic Pericardial Effusion Following Transcutaneous Aortic Valve Replacement\u2014A Case Report"],"prefix":"10.1093","volume":"48","author":[{"given":"Vanya","family":"Jaitly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hlaing","family":"Tint","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alice","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Allison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bindu","family":"Akkanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pranav","family":"Loyalka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,9,8]]},"reference":[{"issue":"24","key":"key\n\t\t\t\t20170916051431_CIT0001","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/j.jacc.2014.08.052","article-title":"Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement","volume":"64","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"key\n\t\t\t\t20170916051431_CIT0002","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.jacc.2013.03.029","article-title":"Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events","volume":"62","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"key\n\t\t\t\t20170916051431_CIT0003","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa1008232","article-title":"Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery","volume":"363","year":"2010","journal-title":"N Engl J Med"},{"issue":"13","key":"key\n\t\t\t\t20170916051431_CIT0004","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1182\/blood-2004-06-2223","article-title":"The use of recombinant factor VIIa in the treatment of bleeding disorders","volume":"104","year":"2004","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170916051431_CIT0005","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/S0268-960X(15)30002-3","article-title":"Recombinant activated factor VII: 30 years of research and innovation","volume":"29","year":"2015","journal-title":"Blood Rev"},{"key":"key\n\t\t\t\t20170916051431_CIT0006","first-page":"11","article-title":"Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery","year":"2000","journal-title":"Blood Coagul Fibrinol"},{"issue":"2","key":"key\n\t\t\t\t20170916051431_CIT0007","article-title":"An effective treatment of severe intractable bleeding after valve repair by one single dose of activated recombinant factor VII","volume":"93","year":"2001","journal-title":"Anesthesia & Analgesia"},{"issue":"1","key":"key\n\t\t\t\t20170916051431_CIT0008","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1537-2995.2005.04216.x","article-title":"Recombinant factor VIIa for intractable blood loss after cardiac surgery: A propensity score-matched case-control analysis","volume":"45","year":"2005","journal-title":"Transfusion"},{"issue":"5","key":"key\n\t\t\t\t20170916051431_CIT0009","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/bja\/aei244","article-title":"Activated recombinant factor VII after cardiopulmonary bypass reduces allogeneic transfusion in complex non-coronary cardiac surgery: Randomized double-blind placebo-controlled pilot study","volume":"95","year":"2005","journal-title":"Br J Anaesth"},{"issue":"4","key":"key\n\t\t\t\t20170916051431_CIT0010","article-title":"Recombinant Factor VIIA in traumatic intracerebral hemmorhage: Results of a dose escalation clinical trial","volume":"62","year":"2008","journal-title":"Neurosurgery"},{"issue":"1","key":"key\n\t\t\t\t20170916051431_CIT0011","article-title":"Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: Two parallel randomized, placebo-controlled, double-blind clinical trials","volume":"59","year":"2005","journal-title":"J Trauma Acute Care Surg"},{"issue":"3","key":"key\n\t\t\t\t20170916051431_CIT0012","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/jama.295.3.293","article-title":"Thromboembolic adverse events after use of recombinant human coagulation factor VIIa","volume":"295","year":"2006","journal-title":"JAMA"},{"issue":"4","key":"key\n\t\t\t\t20170916051431_CIT0013","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/S0003-4975(02)03766-9","article-title":"Effect of blood transfusion on long-term survival after cardiac operation","volume":"74","year":"2002","journal-title":"Ann Thorac Surg"},{"issue":"22","key":"key\n\t\t\t\t20170916051431_CIT0014","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1161\/CIRCULATIONAHA.107.698977","article-title":"Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery","volume":"116","year":"2007","journal-title":"Circulation"},{"issue":"4","key":"key\n\t\t\t\t20170916051431_CIT0015","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1177\/000331979804900404","article-title":"Acute mesenteric ischemia after open heart surgery","volume":"49","year":"1998","journal-title":"Angiology"},{"issue":"3","key":"key\n\t\t\t\t20170916051431_CIT0016","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.athoracsur.2007.10.060","article-title":"Incidence, topography, predictors and long-term survival after stroke in patients undergoing coronary artery bypass grafting","volume":"85","year":"2008","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"key\n\t\t\t\t20170916051431_CIT0017","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.108.834275","article-title":"Safety and efficacy of recombinant activated factor VII","volume":"120","year":"2009","journal-title":"Circulation"},{"issue":"3","key":"key\n\t\t\t\t20170916051431_CIT0018","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/LBR.0000000000000286","article-title":"Intrapulmonary recombinant factor VII as an effective treatment for diffuse alveolar hemorrhage: A case series","volume":"23","year":"2016","journal-title":"J Bronchology Interv Pulmonol"},{"issue":"8","key":"key\n\t\t\t\t20170916051431_CIT0019","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.healun.2009.04.028","article-title":"High incidence of thromboembolic events in left ventricular assist device patients treated with recombinant activated factor VII","volume":"28","year":"2009","journal-title":"J Heart Lung Transplant"},{"key":"key\n\t\t\t\t20170916051431_CIT0020","article-title":"Haemostasis with fibrin glue injection into the pericardial space for right ventricular perforation caused by an iatrogenic procedural complication","volume":"2016","year":"2016","journal-title":"BMJ Case Rep"}],"container-title":["Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/labmed\/article-pdf\/48\/3\/262\/19928548\/lmx048.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,16]],"date-time":"2017-09-16T05:14:41Z","timestamp":1505538881000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/labmed\/article\/48\/3\/262\/4159497\/IntraPericardial-Use-of-Recombinant-Factor-VIIa-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":20,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,9,8]]},"published-print":{"date-parts":[[2017,8]]}},"URL":"https:\/\/doi.org\/10.1093\/labmed\/lmx048","relation":{},"ISSN":["0007-5027","1943-7730"],"issn-type":[{"value":"0007-5027","type":"print"},{"value":"1943-7730","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8]]}}}